These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 11882618)
1. Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading. Martinez DV; Rocha R; Matsumura M; Oestreicher E; Ochoa-Maya M; Roubsanthisuk W; Williams GH; Adler GK Hypertension; 2002 Feb; 39(2 Pt 2):614-8. PubMed ID: 11882618 [TBL] [Abstract][Full Text] [Related]
2. Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury. Oestreicher EM; Martinez-Vasquez D; Stone JR; Jonasson L; Roubsanthisuk W; Mukasa K; Adler GK Circulation; 2003 Nov; 108(20):2517-23. PubMed ID: 14581407 [TBL] [Abstract][Full Text] [Related]
3. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. Rocha R; Martin-Berger CL; Yang P; Scherrer R; Delyani J; McMahon E Endocrinology; 2002 Dec; 143(12):4828-36. PubMed ID: 12446610 [TBL] [Abstract][Full Text] [Related]
4. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats. Tsukamoto O; Minamino T; Sanada S; Okada K; Hirata A; Fujita M; Shintani Y; Yulin L; Asano Y; Takashima S; Yamasaki S; Tomoike H; Hori M; Kitakaze M Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190 [TBL] [Abstract][Full Text] [Related]
5. Effects of Mineralocorticoid Receptor Blockade and Statins on Kidney Injury Marker 1 (KIM-1) in Female Rats Receiving L-NAME and Angiotensin II. Huang J; Caliskan Guzelce E; Gholami SK; Gawelek KL; Mitchell RN; Pojoga LH; Romero JR; Williams GH; Adler GK Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047470 [TBL] [Abstract][Full Text] [Related]
6. Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model. Zhou X; Ono H; Ono Y; Frohlich ED Am J Nephrol; 2004; 24(2):242-9. PubMed ID: 15031627 [TBL] [Abstract][Full Text] [Related]
7. Effects of eplerenone and salt intake on left ventricular remodeling after myocardial infarction in rats. Urabe A; Izumi T; Abe Y; Taniguchi I; Mochizuki S Hypertens Res; 2006 Aug; 29(8):627-34. PubMed ID: 17137219 [TBL] [Abstract][Full Text] [Related]
8. Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury. Pojoga LH; Yao TM; Opsasnick LA; Siddiqui WT; Reslan OM; Adler GK; Williams GH; Khalil RA J Pharmacol Exp Ther; 2015 Oct; 355(1):32-47. PubMed ID: 26183312 [TBL] [Abstract][Full Text] [Related]
10. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats. Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697 [TBL] [Abstract][Full Text] [Related]
11. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats. Bayorh MA; Mann G; Walton M; Eatman D Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838 [TBL] [Abstract][Full Text] [Related]
12. Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. Rossignol P; Ménard J; Fay R; Gustafsson F; Pitt B; Zannad F J Am Coll Cardiol; 2011 Nov; 58(19):1958-66. PubMed ID: 22032706 [TBL] [Abstract][Full Text] [Related]
13. Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Rocha R; Stier CT; Kifor I; Ochoa-Maya MR; Rennke HG; Williams GH; Adler GK Endocrinology; 2000 Oct; 141(10):3871-8. PubMed ID: 11014244 [TBL] [Abstract][Full Text] [Related]
14. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. Endemann DH; Touyz RM; Iglarz M; Savoia C; Schiffrin EL Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913 [TBL] [Abstract][Full Text] [Related]
15. Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice. Kagiyama S; Matsumura K; Goto K; Otsubo T; Iida M Regul Pept; 2010 Feb; 160(1-3):133-9. PubMed ID: 19969025 [TBL] [Abstract][Full Text] [Related]
16. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury. Hattori T; Murase T; Sugiura Y; Nagasawa K; Takahashi K; Ohtake M; Ohtake M; Miyachi M; Murohara T; Nagata K Hypertens Res; 2014 Feb; 37(2):125-33. PubMed ID: 24048492 [TBL] [Abstract][Full Text] [Related]
17. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions. Wang H; Shimosawa T; Matsui H; Kaneko T; Ogura S; Uetake Y; Takenaka K; Yatomi Y; Fujita T J Hypertens; 2008 Jul; 26(7):1453-62. PubMed ID: 18551023 [TBL] [Abstract][Full Text] [Related]
18. Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension. Takeda Y Hypertens Res; 2009 May; 32(5):321-4. PubMed ID: 19300447 [TBL] [Abstract][Full Text] [Related]
19. Systemic Aldosterone, But Not Angiotensin II, Plays a Pivotal Role in the Pathogenesis of Renal Injury in Chronic Nitric Oxide-Deficient Male Rats. Suehiro T; Tsuruya K; Ikeda H; Toyonaga J; Yamada S; Noguchi H; Tokumoto M; Kitazono T Endocrinology; 2015 Jul; 156(7):2657-66. PubMed ID: 25872005 [TBL] [Abstract][Full Text] [Related]
20. Role of brain corticosterone and aldosterone in central angiotensin II-induced hypertension. Huang BS; White RA; Ahmad M; Leenen FH Hypertension; 2013 Sep; 62(3):564-71. PubMed ID: 23856493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]